WRF
GH icon

Waddell & Reed Financial’s Guardant Health GH Stock Holding History

Waddell & Reed Financial’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-180,000
Closed -$6.77M – 505
2018
Q4 		$6.77M Buy
+180,000
New +$6.63M 0.02% 437

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return
VS
VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Waddell & Reed Financial's GH Position: Q1 2019 in Review

Waddell & Reed Financial sold out of Guardant Health (GH) in Q1 2019, closing a stake of 180,000 shares — an estimated $6.77M sold.

Waddell & Reed Financial first reported a position in GH in Q4 2018 and held it in 1 quarter. The position peaked at $6.77M in Q4 2018. 150 funds tracked by Wall St. Rank hold GH as of Q1 2019.

  • Waddell & Reed Financial reported no remaining Guardant Health position as of Q1 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 180,000 Guardant Health shares in Q1 2019, an estimated $6.77M.
  • Waddell & Reed Financial first reported a position in Guardant Health in Q4 2018 and held it in 1 quarter.
  • Waddell & Reed Financial's Guardant Health position peaked at $6.77M in Q4 2018.
  • 150 funds tracked by Wall St. Rank held Guardant Health as of Q1 2019.

Based on Waddell & Reed Financial's 13F filing for Q1 2019, filed 15 May 2019.